Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes
Description of Invention:
The invention covers a series of peptide fragments of hepatitis C virus core protein and their use as activators of cytotoxic T lymphocytes. The peptides can be used as vaccines or components of vaccines to prevent hepatitis C. Besides the peptide fragments, pharmaceutical compositions and methods of immunization and diagnostics are also claimed.
Inventors:
JA Berzofsky (NCI) SM Feinstone (FDA) M Shirai (NCI)
